INTRODUCTION {#sec1-1}
============

Various broadly accepted theories of origin exist about facial growth disturbances in patients suffering from Pierre Robin sequence (PRS).

In 1923, Robin initially reported the association between retrognathia/micrognathia and glossoptosis.\[[@ref1]\] In the course of time, a theory originated that the observed under-development of the mandible and its adjacent anatomical structures occur due to gestational oligohydramnios or polyhydramnios. In 1985, Edwards and Newall\[[@ref2]\] concluded that a purely mechanistic etiopathogenesis such as the oligohydramnios theory could not be supported when reviewing the subject-specific scientific literature. They hypothesised that more likely, the combination of a metabolic disorder, together with a secondary intrauterine mechanical obstruction or restriction of mandibular growth, causes the mandibular growth disorder. They, therefore, suggested abolishing the term anomalad and introducing the term maxillomandibular dysgenesis or syndrome instead. Furthermore, they considered making the diagnosis irrespective of the degree of mandibular micrognathia, especially because PRS could result in the first line due to a metabolic disorder which prevented the elevation and fusion of the palatal shelves.\[[@ref2]\] Consecutively, an assumption arose that the mandibular growth disturbance, due to intrauterine mechanical restriction or neurophysiological factors,\[[@ref3]\] might be compensated for by postpartum "catch-up" growth. The observation that without apparent reason, both hypoplastic midfacial structures and/or mandible occur in this type of facial malformation, led to the hypothesis of an underlying inherited bimaxillary growth disorder based on organogenetic factors.\[[@ref4]\]

In Part 3 of this publication, three broadly accepted biological theories related to facial growth disturbances in patients with PRS have been compared with the clinical findings from a database of 266 Siebold-Robin sequence (SRS) and Fairbairn-Robin triad (FRT) cases.

MATERIALS AND METHODS {#sec1-2}
=====================

The 266 PRS cases analyzed in this research were divided into two groups, namely,

SRS clinically diagnosed as micro- or retro-gnathia with glossoptosis, with or without airway obstructionFRT with the clinical features of SRS as well as a cleft palate.

Three prominent theories related to accompanying facial growth disturbances in patients suffering from PRS have been compared to the clinical findings in this presented database:

Gestational oligo- or poly-hydramnios leading to intrauterine restriction of embryonic/fetal movement with consecutive mandibular growth disturbancePostnatal mandibular catch-up growth resulting to a large extent in recovery of mandibular-related facial deformitiesBoth midfacial hypo- and hyper-plasia being assumed to occur due to midfacial growth disturbances.

RESULTS {#sec1-3}
=======

Of the total of 266 cases reviewed, only 169 (63.5%) PRS patients and their mothers attended a follow-up appointment where information about pregnancy history, catch-up growth, and midfacial appearance could be gathered \[Tables [1](#T1){ref-type="table"}--[3](#T3){ref-type="table"}\]. The remaining patients could not be followed up with due to unknown addresses or reasons such as age, indisposition, and/or disinterest.
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Where available, information was obtained from the obstetrics notes of a patient\'s mother regarding prenatal oligo- or poly-hydramnios and where these two conditions were reviewed and evaluated with the mother.

Catch-up growth was not evaluated in infants younger than 24 months.

Midfacial appearance was documented under the headline of clinical appearances and verified by a second craniomaxillofacial surgeon.

Cephalometric analysis was performed in children of 14 years and older.

Oligohydramnios and polyhydramnios {#sec2-1}
----------------------------------

[Table 1](#T1){ref-type="table"} highlights the comparison of the records of SRS and FRT patients regarding gestational oligo- and poly-hydramnios.

A pregnancy history could be retrieved in 169 (63.5%) of the 266 patients. Whereas oligohydramnios was noted in 20.5% (32 of 156) among patients with FRT and 61.5% (8 of 13) with SRS and polyhydramnios was registered in 6.4% (10 of 156) patients with FRT and 7.7% (1 of 13) with SRS \[[Figure 1](#F1){ref-type="fig"}\].\[[@ref5]\]

![Oligohydramnios and polyhydramnios](AMS-6-38-g004){#F1}

Occurrence of catch-up growth {#sec2-2}
-----------------------------

[Table 2](#T2){ref-type="table"} highlights the detailed analysis of syndromic and nonsyndromic SRS and FRT cases, oligo- or poly-hydramnios and positive family history with mandibular catch-up and noncatch-up growth.

Mandibular catch-up \[Figure [2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\] and noncatch-up growth \[Figure [3a](#F3){ref-type="fig"} and [b](#F3){ref-type="fig"}\] were evaluated in 59.8% (159 of 266) of the patients in this database. Whereas none of the 13 evaluated SRS cases revealed catch-up growth, 34.9% (51 of 146) of FRT patients presented with catch-up growth \[[Figure 4](#F4){ref-type="fig"}\],\[[@ref5]\]82.4% (42 of 51) of which were nonsyndromic cases.

![(a and b) Mandibular catch-up growth in Fairbairn-Robin triad](AMS-6-38-g005){#F2}

![(a and b) Mandibular noncatch-up growth in Fairbairn-Robin triad](AMS-6-38-g006){#F3}

![Catch-up growth in Fairbairn-Robin triad](AMS-6-38-g007){#F4}

It has been discovered that in 17.6% (9 out of 51) of FRT patients showing mandibular catch-up growth, the mother suffered from oligo- or poly-hydramnios during pregnancy. Furthermore, it has been noted that 27.5% (14 of 51) of FRT patients revealed a cleft lip palate positive family history.

Midfacial appearances {#sec2-3}
---------------------

[Table 3](#T3){ref-type="table"} provides a survey of the midfacial appearances of 174 SRS and FRT patients.

Midfacial appearances were evaluated in 65.4% of this database. Of the 17 SRS patients, 6 (35.3%) presented with midfacial hyperplasia and none with hypoplasia. Among the FRT patients, 22.3% (35 of 157) displayed a midfacial hyperplasia and only seven (4.5%) presented with hypoplasia \[[Figure 5](#F5){ref-type="fig"}\]. All seven cases with midfacial hypoplasia had a Binderoid appearance \[Figures [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}\]. Two of these were siblings with a genetically proven Stickler syndrome.
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![A binderoid midfacial appearance of a Fairbairn-Robin triad](AMS-6-38-g010){#F7}

DISCUSSION {#sec1-4}
==========

It has been stated that too little (= oligohydramnios) as well as too much (= polyhydramnios) amniotic fluid might lead to postnatal compromised airways with associated malformations as found in SRS/FRT.\[[@ref6]\] One of the most widespread theories related to the origin of SRS/FRT in new-borns involves the existence of oligohydramnios during the mother\'s pregnancy. Oligohydramnios is believed to cause limitation of the normal extension range of the flexed fetal head. This limitation in turn presents a hindrance to mandibular growth due to mechanical compression of the mandible onto the sternum. It is deemed that this restricted mandibular growth inhibits the downward and forward movement of the tongue, thereby impeding the elevation and fusion of the palatal shelves.\[[@ref7][@ref8]\] This restricted growth was the motivation behind the change in terminology from Pierre Robin syndrome to anomalad as the latter is defined as a malformation with subsequent structural changes.\[[@ref9][@ref10]\]

In addition, downward and forward movement of the tongue becomes restricted, thereby resulting in microglossia secondary to compromised mandibular growth. This further impedes the elevation and fusion of the palatal shelves,\[[@ref7][@ref8]\] resulting in a cleft palate malformation (FRT). Experiments on rats\[[@ref7][@ref8]\] provided scientific support to back up the theory of mandibular catch-up growth.

Contrary to the popular origin theory that oligohydramnios is the major contributing factor, certain publications dealing with prenatal SRS/FRT diagnosis consider polyhydramnios to also be a risk factor for PRS.\[[@ref10][@ref11]\] Polyhydramnios is presumed to be the result of intrauterine decreased fetal swallowing, which in turn causes a retro- or even micro-gnathia with a consecutive cleft palate malformation.

Sonographic findings of oligo- or poly-hydramnios should thus be carefully recorded and detection should alert clinicians to the possibility of developing SRS/FRT or other common characteristics of these entities, such as micro- or retro-gnathia with or without microglossia and cleft palate malformations.\[[@ref12]\] If aforementioned conditions are present during a sonographic scan, it is recommended that the heart be screened as well, especially as cardiac abnormalities are reported in 20% of patients diagnosed with micrognathia.\[[@ref6][@ref13]\] Whereas 3.4% of all patients evaluated in this database presented with a cardiac abnormality, only one SRS patient, whose mother reported polyhydramnios during pregnancy, suffered from a congenital heart defect. This rather low percentage sharply contrasts a 50% occurrence of congenital heart defects in FRT patients with a prenatal history of oligohydramnios. Karyotyping of the fetus has been recommended as chromosomal abnormalities have been discovered in 45% of a patient sample where micrognathia had been diagnosed sonographically.\[[@ref6]\] In this database, chromosomal/genetic abnormalities have been confirmed in only 13.5% of all cases.

In the database under discussion, 63.5% of the records provided information relating to maternal oligo- and poly-hydramnios during pregnancy. Whereas mothers with oligohydramnios were recorded in 20.5% of FRT and 61.5% of SRS patients, those with polyhydramnios prevailed in only 6.4% of FRT and 7.7% of SRS patients.

The oligohydramnios/polyhydramnios theory as an origin of PRS is broadly acknowledged within the professional community. However, the overall incidence of 30.2%, i.e. 23.7% for oligohydramnios and 6.5% for polyhydramnios presented in this database \[[Table 1](#T1){ref-type="table"}\], suggests that it should be kept in perspective. That said, oligohydramnios is nevertheless strongly represented in the SRS division with 61.5% whereas it is relatively low with only 20.5% in the FRT division. Therefore, it seems that the oligohydramnios and polyhydramnios theories might be considered to be strongly causative for intrauterine mandibular growth disorder in patients with SRS while they might be deemed to be of less importance in FRT patients.

The mandibular catch-up growth theory is highly controversial. A number of cephalometric studies have not been able to substantiate catch-up growth.\[[@ref14][@ref15]\] As multiple structural middle and inner ear defects were found in one postmortem case,\[[@ref16]\] partial abnormalities of Meckel\'s cartilage might be considered to be involved in the pathogenesis of SRS/FRT.\[[@ref17]\] Conversely, this argues for a postnatal mandibular noncatch-up growth. Many authors\[[@ref11][@ref17]\] however, commented on the notion of mandibular catch-up growth. This is believed to occur postnatal due to an inherent normal mandibular growth potential as soon as the intrauterine mechanical growth restriction due to oligohydramnios ends.

Syndromic patients are considered to have a primary mandibular growth disorder and therefore do not show any postnatal potential for catch-up growth.\[[@ref18][@ref19]\] When comparing 2-year-old children suffering from nonsyndromic SRS/FRT and isolated cleft palate (ICP) with unimpaired children, a significantly faster increase of mandibular length was detected in children with SRS/FRT.\[[@ref15]\]

However, another study comparing toddlers suffering from SRS/FRT with unimpaired children during their 1^st^ year of life did not discover any mandibular growth difference between the two groups.\[[@ref16]\] In 2001, Daskalogiannakis *et al*.\[[@ref17]\] noted no catch-up growth in patients with SRS/FRT or in patients with ICP after the age of 5 years. This finding was later confirmed by others matching the mandibular growth between ICP patients and patients with nonsyndromic SRS/FRT up to the age of 22 months.\[[@ref18]\]

Thus far, the evidence indicates that depending on the etiology of intrauterine growth restriction due to oligo- or poly-hydramnios, mandibular catch-up growth does occur, but not sufficiently to produce a postnatal normal facial profile with a normal jaw.\[[@ref17]\]

As represented in [Table 2](#T2){ref-type="table"}, mandibular catch-up growth was observed in the represented database in 34.9% of FRT patients of whom 82.4% were nonsyndromic. In the noncatch-up growth group, 82.1% were nonsyndromic FRT patients and 84.6% were nonsyndromic SRS patients. These results seem to confirm that slightly more than one-third of the patients with FRT might experience mandibular catch-up growth, the majority of them being nonsyndromic.

Furthermore, 27.5% in the FRT catch-up growth group had a family history of cleft lip and/or palate. However, a prenatal history of oligo- or poly-hydramnios was revealed in only 17.4% of FRT patients with mandibular catch-up growth. These database results challenge both theories: Oligohydramnios with intrauterine mechanical mandibular growth restriction, as well as the theory that postnatal mandibular catch-up growth occurs once the intrauterine compromise to the mandibular growth pattern has subsided.

Existing midfacial hypoplasia in patients with SRS/FRT is interesting, especially in light of the view that the mandible is micro- or retro-gnathic, thereby accentuating the facial deformity in the anteroposterior dimension. An evaluation by means of computerized morphometric facial analysis in SRS/FRT infants found substantial midfacial hypoplasia, together with,

A virtually normal anterior maxillary vertical developmentA significantly reduced posterior height of the maxilla.\[[@ref20]\]

In 2001, Daskalogiannakis *et al*.\[[@ref17]\] supported the lack of maxillary growth in a cephalometric analysis. In their study, they compared maxillary growth of postoperative PRS with that of ICP patients and noted that the anteroposterior midfacial dimension in PRS patients was significantly shorter. However, it remains unclear whether the investigated cases represent cases with true midfacial hypoplasia, or whether they show a compensatory midfacial hyperplasia due to a relatively less pronounced mandibular micrognathia. In PRS, the micro-/retro-gnathia appears more severe due to a midfacial "hyperplasia" because platybasia (cranial base angle ≥137°) as found, or is this only a relative appearance due to the platybasia?\[[@ref21]\] These findings are analogous to those of Amaratunga\[[@ref22]\] who had followed-up patients with midfacial hypoplasia for a minimum of 2 years. Similar findings were confirmed in a more recent three-dimensional assessment.\[[@ref23]\]

Results from the analysis of the study database exhibit various types of midfacial appearances for patients with SRS and FRT. In SRS group, midfacial hyperplasia occurred in 35.3% of the study patients without any cases of hypoplasia. On the contrary, patients with FRT revealed manifold midfacial appearances such as those documented in [Table 3](#T3){ref-type="table"}:

Midfacial hypoplasia: 4.5%Hyperplasia: 22.3%Normal midfacial appearance: 73.2%.

These findings are contrary to those previously published.\[[@ref17][@ref19][@ref22][@ref23]\]

A wide U-shaped hard and soft palate cleft is usually found in FRT patients. It is worth considering whether midfacial hypoplasia in FRT patients can be considered to be a sequel of extensive palatal surgery. It would be particularly significant to establish whether it is due to specific reconstructive procedure (s) and/or the timing of primary cleft surgery and/or possible additional velopharyngeal surgery. Important questions to consider here are the following:

Could future facial dysgnathic growth patterns be the result of surgical procedures, especially those involving extensive palatal mucoperiosteal stripping, as well as the time lapse between birth and the surgical intervention (s)?Would the mandible still show relative catch-up growth in such cases with midfacial growth restriction when examining them as adolescents in cephalometric analysis?

On the other hand, a hyperplastic midface in neonates, as found in 23.6% of this database, exacerbates the appearance of a mandibular hypoplasia. During growth, such children and future adolescents may present with a much more normal relationship in the anteroposterior dimension of the face due to previous cleft surgery, with or without velopharyngeal reconstruction or due to a platybasic skull base.

In the field of PRS research, this disorder is generally accepted as an inhomogeneous facial malformation consisting of two main groups, the SRS and FRT with possible additional subdivisions, each presenting with different facial growth patterns. This study compared various craniomaxillofacial tenets, related to facial growth disturbances in patients with PRS with clinical findings from a database of 266 SRS and FRT cases. Findings in scientific literature related to oligo- and poly-hydramnios, mandibular catch-up growth, and midfacial hypo- and hyper-plasia tenets in PRS patients could only partially be supported. Although gray areas still exist, these clinical findings might widen the scope of discussion, thus providing a platform for future research.

CONCLUSION {#sec1-5}
==========

The three main biological theories regarding PRS could not be verified after thorough analysis of the database.
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